SCHEMBL3278686

SCHEMBL3278686

COc1ccccc1CNc1ccc2cc(NCCCn3ccnc3)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 8/20 0.48
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TLR9 Q9NR96 1/20 0.47
TLR7 Q9NYK1 1/20 0.47
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
HTR1A P08908 2/20 0.45
NAMPT P43490 2/20 0.43
SOD1 P00441 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3267065 0.82 MEN1 (0.53) ALDH1A1L3MBTL1KDM4EGAACYP1A2
SCHEMBL3268014 0.79 MAPT (0.43) ALDH1A1PKML3MBTL1KDM4EGAA
SCHEMBL3268616 0.77 PDGFRB (0.53) ALDH1A1KDM4EGAACYP1A2CYP3A4
SCHEMBL3266795 0.77 CYP2D6 (0.47) ALDH1A1PKMKDM4EGAACYP1A2
SCHEMBL3275354 0.77 MAPT (0.43) ALDH1A1PKML3MBTL1KDM4EGAA
SCHEMBL3267015 0.76 MEN1 (0.47) ALDH1A1L3MBTL1KDM4EGAACYP1A2
SCHEMBL3268321 0.76 CYP1A2 (0.53) ALDH1A1KDM4EGAANAMPTCYP1A2
SCHEMBL3266911 0.76 AURKA (0.54) ALDH1A1KDM4EGAACYP1A2CYP3A4
SCHEMBL3267055 0.75 LMNA (0.53) ALDH1A1KDM4EGAAHTR1ACYP1A2
SCHEMBL3268223 0.75 QRFPR (0.50) ALDH1A1KDM4EGAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399674-B2 Quinolines HOFFMAN-LA ROCHE INC. (US) 2013-03-19 US disclosed
US-20120136018-A1 QUINOLINES KOLCZEWSKI SABINE (DE) 2012-05-31 US disclosed
EP-2195296-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-06-16 EP disclosed
US-20090088451-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 US disclosed
WO-2009040290-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088451-A1 QUINOLINES HTR5A, HTR1A, HTR1E QPCT 400/4885ALDH1A1 961/4885PKM 3435/4885
US-20120136018-A1 QUINOLINES HTR5A, HTR1A, HTR1E QPCT 400/4885ALDH1A1 961/4885PKM 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.